Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice
The cell-penetrating peptide GV1001 has been investigated as an anticancer agent and recently demonstrated anti-oxidant and anti-inflammatory effects. It has shown a protective effect on a kanamycin (KM)-induced ototoxicity mouse model. In the present study, we administered GV1001 at different time...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2018-01-01
|
| 叢編: | Frontiers in Cellular Neuroscience |
| 主題: | |
| 在線閱讀: | http://journal.frontiersin.org/article/10.3389/fncel.2018.00003/full |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|